🇺🇸 FDA
Patent

US 10604499

MYC G-quadruplex stabilizing small molecules and their use

granted A61KA61K31/343A61K31/397

Quick answer

US patent 10604499 (MYC G-quadruplex stabilizing small molecules and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/343, A61K31/397, A61K31/4025, A61K31/439